查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1390554

骨科生物製剂市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Orthobiologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球骨科生物製品市场规模达57亿美元。展望未来， IMARC Group预计到2028年市场规模将达到77亿美元，2022-2028年复合年增长率（CAGR）为5.14%。

骨生物製剂是利用体内天然存在的物质（例如碳水化合物、蛋白质、细胞和糖蛋白）製成的组织衍生产品。它们有助于减轻疼痛和炎症，逆转骨关节炎的衰弱影响，并促进软骨再生、肌腱癒合、韧带修復和骨形成的过程。一些常用的骨科生物疗法包括干细胞、富血小板血浆 (PRP)、自体条件血浆 (ACP) 和骨髓抽吸浓缩液 (BMAC)。其中，PRP 作为一种新颖的治疗方式在全球范围内受到关注，在各种肌肉骨骼疾病中副作用最小。这些病症包括肩袖撕裂、肩峰下撞击、肩部骨关节炎、髌腱变性、外上髁肌腱病变和膝骨关节炎。

骨科生物製剂市场趋势：

骨科生物製剂有助于专业和休閒运动员的运动相关损伤的快速康復。个人越来越多地参与体育运动是对市场产生正面影响的主要因素之一。除此之外，由于身体的退化性变化，老年人可能会出现肩袖撕裂。这与老年人口的成长相结合，推动了市场的成长。此外，久坐的生活方式、不健康的饮食模式和慢性病的流行也会增加骨关节炎的风险。此外，用于侵入性手术的几种骨科生物製剂可以在保险范围内报销，这正在加强市场的成长。此外，人们越来越认识到与骨科生物疗法相关的好处，例如避免关节置换等重大侵入性手术和快速恢復时间，正在促进其相对于其他外科手术的采用。除此之外，骨科手术数量的增加以及骨折固定用生物可吸收植入物的需求不断增加，促进了骨科生物製品的使用，例如自体移植骨和同种异体移植骨以及脱矿骨基质在儿科人群中的使用。

本报告回答的关键问题：

  • 迄今为止，全球骨科生物製品市场表现如何，未来几年将如何表现？
  • COVID-19 对全球骨科生物製剂市场有何影响？
  • 主要区域市场有哪些？
  • 基于产品的市场区隔是什么？
  • 依类型划分市场是怎么样的？
  • 基于应用程式的市场区隔是什么？
  • 基于最终用户的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球骨科生物製品市场的结构如何？谁是主要参与者？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球骨科生物製品市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按产品分類的市场区隔

  • 去矿骨基质
    • 市场走向
    • 市场预测
  • 同种异体移植物
    • 市场走向
    • 市场预测
  • 骨形态发生蛋白
    • 市场走向
    • 市场预测
  • 黏稠补充产品
    • 市场走向
    • 市场预测
  • 合成骨替代品
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：按类型分類的市场细分

  • 膝盖
    • 市场走向
    • 市场预测
  • 踝
    • 市场走向
    • 市场预测
  • 时髦的
    • 市场走向
    • 市场预测
  • 手腕和肩膀
    • 市场走向
    • 市场预测
  • 脊椎
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：按应用分類的市场区隔

  • 骨关节炎和退化性关节炎
    • 市场走向
    • 市场预测
  • 脊椎融合术
    • 市场走向
    • 市场预测
  • 骨折恢復
    • 市场走向
    • 市场预测
  • 软组织损伤
    • 市场走向
    • 市场预测
  • 颚面和牙科应用
    • 市场走向
    • 市场预测

第 9 章：最终用户的市场区隔

  • 医院及门诊中心
    • 市场走向
    • 市场预测
  • 研究和学术机构
    • 市场走向
    • 市场预测
  • 牙科诊所和设施
    • 市场走向
    • 市场预测
  • 骨科诊所
    • 市场走向
    • 市场预测

第 10 章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Arthrex Inc
    • Globus Medical Inc.
    • Integra LifeSciences
    • Johnson & Johnson
    • Medline Industries Inc.
    • Medtronic plc
    • NuVasive Inc
    • Orthofix Medical Inc.
    • Smith & Nephew plc
    • Stryker Corporation
    • Terumo Corporation
    • Wright Medical Group NV
    • Zimmer Biomet
Product Code: SR112023A4332

Abstract

The global orthobiologics market size reached US$ 5.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.14% during 2022-2028.

Orthobiologics are tissue-derived products made using substances that are naturally found in the body, such as carbohydrates, proteins, cells, and glycoproteins. They assist in reducing pain and inflammation, reversing debilitating effects of osteoarthritis, and facilitating the process of cartilage regeneration, tendon healing, ligament repairing, and bone formation. Some of the commonly utilized orthobiologic therapies are stem cells, platelet-rich plasma (PRP), autologous conditioned plasma (ACP), and bone marrow aspirate concentrate (BMAC). Amongst these, PRP is gaining traction across the globe as novel treatment modalities with minimal side effects in diverse musculoskeletal conditions. These conditions include rotator cuff tears, sub-acromial impingement, shoulder osteoarthritis, patellar tendinosis, lateral epicondylar tendinopathy, and knee osteoarthritis.

Orthobiologics Market Trends:

Orthobiologics aid in the quick recovery of sports-related injuries among professional and recreational athletes. The increasing participation of individuals in sports and physical activities represents one of the major factors influencing the market positively. Apart from this, rotator cuff tears can appear among older people due to degenerative changes in the body. This, in confluence with the growing geriatric population, is impelling the market growth. Moreover, the risk of developing osteoarthritis can be increased due to sedentary lifestyles, unhealthy dietary patterns, and the prevalence of chronic diseases. In addition, several orthobiologics utilized for invasive surgeries can be reimbursed under insurance coverage, which is strengthening the market growth. Furthermore, the growing awareness about the benefits associated with orthobiologic therapies, such as avoiding major invasive surgery like joint replacement and fast recovery time, is promoting their adoption over other surgical procedures. Besides this, the increasing number of orthopedic surgeries and the escalating demand for bioabsorbable implants for fracture fixation is contributing to the use of orthobiologics, such as autograft and allograft bone, and demineralized bone matrix, among the pediatric population.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global orthobiologics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, type, application and end user.

Breakup by Product:

Demineralized Bone Matrix

Allograft

Bone Morphogenetic Protein

Viscosupplementation Products

Synthetic Bone Substitutes

Others

Breakup by Type:

Knee

Ankle

Hip

Wrist and Shoulder

Spine

Others

Breakup by Application:

Osteoarthritis and Degenerative Arthritis

Spinal Fusion

Fracture Recovery

Soft Tissue Injuries

Maxillofacial and Dental Applications

Breakup by End User:

Hospitals and Ambulatory Centers

Research and Academic Institutes

Dental Clinics and Facilities

Orthopedic Clinics

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc, Globus Medical Inc., Integra LifeSciences, Johnson & Johnson, Medline Industries Inc., Medtronic plc, NuVasive Inc, Orthofix Medical Inc., Smith & Nephew plc, Stryker Corporation, Terumo Corporation, Wright Medical Group N.V. and Zimmer Biomet.

Key Questions Answered in This Report:

  • How has the global orthobiologics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global orthobiologics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global orthobiologics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Orthobiologics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Demineralized Bone Matrix
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Allograft
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Bone Morphogenetic Protein
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Viscosupplementation Products
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Synthetic Bone Substitutes
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Knee
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Ankle
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Hip
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Wrist and Shoulder
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Spine
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Osteoarthritis and Degenerative Arthritis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Spinal Fusion
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Fracture Recovery
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Soft Tissue Injuries
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Maxillofacial and Dental Applications
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Ambulatory Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Research and Academic Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Dental Clinics and Facilities
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Orthopedic Clinics
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Arthrex Inc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 SWOT Analysis
    • 15.3.2 Globus Medical Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Integra LifeSciences
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Johnson & Johnson
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Medline Industries Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 Medtronic plc
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 NuVasive Inc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Orthofix Medical Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Smith & Nephew plc
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Stryker Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Terumo Corporation
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Wright Medical Group N.V.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 SWOT Analysis
    • 15.3.13 Zimmer Biomet
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Orthobiologics Market: Major Drivers and Challenges
  • Figure 2: Global: Orthobiologics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Orthobiologics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Orthobiologics Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Orthobiologics Market: Breakup by Type (in %), 2022
  • Figure 6: Global: Orthobiologics Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Orthobiologics Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Orthobiologics Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Orthobiologics (Demineralized Bone Matrix) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Orthobiologics (Demineralized Bone Matrix) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Orthobiologics (Allograft) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Orthobiologics (Allograft) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Orthobiologics (Bone Morphogenetic Protein) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Orthobiologics (Bone Morphogenetic Protein) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Orthobiologics (Viscosupplementation Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Orthobiologics (Viscosupplementation Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Orthobiologics (Synthetic Bone Substitutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Orthobiologics (Synthetic Bone Substitutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Orthobiologics (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Orthobiologics (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Orthobiologics (Knee) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Orthobiologics (Knee) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Orthobiologics (Ankle) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Orthobiologics (Ankle) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Orthobiologics (Hip) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Orthobiologics (Hip) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Orthobiologics (Wrist and Shoulder) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Orthobiologics (Wrist and Shoulder) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Orthobiologics (Spine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Orthobiologics (Spine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Orthobiologics (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Orthobiologics (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Orthobiologics (Osteoarthritis and Degenerative Arthritis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Orthobiologics (Osteoarthritis and Degenerative Arthritis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Orthobiologics (Spinal Fusion) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Orthobiologics (Spinal Fusion) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Orthobiologics (Fracture Recovery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Orthobiologics (Fracture Recovery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Orthobiologics (Soft Tissue Injuries) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Orthobiologics (Soft Tissue Injuries) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Orthobiologics (Maxillofacial and Dental Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Orthobiologics (Maxillofacial and Dental Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Orthobiologics (Hospitals and Ambulatory Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Orthobiologics (Hospitals and Ambulatory Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Global: Orthobiologics (Research and Academic Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Global: Orthobiologics (Research and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Global: Orthobiologics (Dental Clinics and Facilities) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Global: Orthobiologics (Dental Clinics and Facilities) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Global: Orthobiologics (Orthopedic Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Global: Orthobiologics (Orthopedic Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: North America: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: North America: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: United States: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: United States: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Canada: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Canada: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Asia-Pacific: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Asia-Pacific: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: China: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: China: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Japan: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Japan: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: India: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: India: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: South Korea: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: South Korea: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Australia: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Australia: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Indonesia: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Indonesia: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Others: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Others: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Europe: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Europe: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Germany: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Germany: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: France: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: France: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: United Kingdom: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: United Kingdom: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Italy: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Italy: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Spain: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Spain: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Russia: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Russia: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Others: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Others: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Latin America: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Latin America: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Brazil: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Brazil: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Mexico: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 94: Mexico: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Others: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 96: Others: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 97: Middle East and Africa: Orthobiologics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 98: Middle East and Africa: Orthobiologics Market: Breakup by Country (in %), 2022
  • Figure 99: Middle East and Africa: Orthobiologics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 100: Global: Orthobiologics Industry: SWOT Analysis
  • Figure 101: Global: Orthobiologics Industry: Value Chain Analysis
  • Figure 102: Global: Orthobiologics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Orthobiologics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Orthobiologics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Orthobiologics Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 4: Global: Orthobiologics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Orthobiologics Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Orthobiologics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Orthobiologics Market: Competitive Structure
  • Table 8: Global: Orthobiologics Market: Key Players